Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (170)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hahnen, E.
Right arrow Articles by Wirth, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahnen, E.
Right arrow Articles by Wirth, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

OTHER

Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals

Eric Hahnen, Randolf Forkert, Christine Marke, Sabine Rudnik-Schöneborn, Jutta Schönling, Klaus Zerres, T. Creavin and Brunhilde Wirth*

Institute of Human Genetics Wilhelmstrasse 31, 53111 Bonn, Germany

*To whom correspondence should be addressed

Received June 6, 1995; Revised July 26, 1995; Accepted July 26, 1995

Proximal spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder characterized by degeneration of anterior horn cells in the spinal cord leading to weakness and wasting of voluntary muscles. Here we present the molecular analysis of both SMA candidate genes, the survival motor neuron gene (SMN; exons 7 and 8) and the neuronal apoptosis inhibitory protein gene (NAIP; exons 5, 6 and 13), in 195 patients and 348 parents of SMA families mainly of German origin. The SMN gene is homozygously deleted for both exons 7 and 8 or exon 7 only in 96% of type I SMA, 94% of type II SMA and 82% of type III SMA as well as in 0.3% of SMA parents. The NAIP gene is homozygously deleted in 46% of type I SMA, 17% of type II SMA, 7% of type III SMA and 2% of SMA parents. The frequencies of deletions in patients for both genes, SMN and NAIP, correspond to those for the NAIP gene only. SMA patients of this series who did not show deletions were clinically Indistinguishable from deleted patients. In addition to one unaffected mother of a type II SMA patient, we found homozygous deletions of the SMN gene exons 7 and 8 in six further unaffected individuais, all sibs of type II and III patients. These belonged to four families with affected and unaffected sibs who showed identical haplotypes for all SMA flanking markers; therefore, we had regarded these families as chromosome 5 unlinked. All seven unaffected individuals in whom we detected SMA deletions do not show any signs of muscle weakness and are physically inconspicuous. The largest divergence between age at onset of an affected subject and the present age of unaffected deleted sibs is four decades now. The occurrence of SMN deletions in unaffected individuals suggests that other genes or mechanisms may be necessary to produce the SMA phenotype.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
K. Meyer, J. Marquis, J. Trub, R. Nlend Nlend, S. Verp, M.-D. Ruepp, H. Imboden, I. Barde, D. Trono, and D. Schumperli
Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation
Hum. Mol. Genet., February 1, 2009; 18(3): 546 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Hauke, M. Riessland, S. Lunke, I. Y. Eyupoglu, I. Blumcke, A. El-Osta, B. Wirth, and E. Hahnen
Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition
Hum. Mol. Genet., January 15, 2009; 18(2): 304 - 317.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
G. E. Oprea, S. Krober, M. L. McWhorter, W. Rossoll, S. Muller, M. Krawczak, G. J. Bassell, C. E. Beattie, and B. Wirth
Plastin 3 Is a Protective Modifier of Autosomal Recessive Spinal Muscular Atrophy
Science, April 25, 2008; 320(5875): 524 - 527.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
O. Biondi, C. Grondard, S. Lecolle, S. Deforges, C. Pariset, P. Lopes, C. Cifuentes-Diaz, H. Li, B. della Gaspera, C. Chanoine, et al.
Exercise-Induced Activation of NMDA Receptor Promotes Motor Unit Development and Survival in a Type 2 Spinal Muscular Atrophy Model Mouse
J. Neurosci., January 23, 2008; 28(4): 953 - 962.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J. van Bergeijk, K. Rydel-Konecke, C. Grothe, and P. Claus
The spinal muscular atrophy gene product regulates neurite outgrowth: importance of the C terminus
FASEB J, May 1, 2007; 21(7): 1492 - 1502.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
T. T. Le, L. T. Pham, M. E.R. Butchbach, H. L. Zhang, U. R. Monani, D. D. Coovert, T. O. Gavrilina, L. Xing, G. J. Bassell, and A. H.M. Burghes
SMN{Delta}7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN
Hum. Mol. Genet., March 15, 2005; 14(6): 845 - 857.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Majumder, S. Varadharaj, K. Ghoshal, U. Monani, A. H. M. Burghes, and S. T. Jacob
Identification of a Novel Cyclic AMP-response Element (CRE-II) and the Role of CREB-1 in the cAMP-induced Expression of the Survival Motor Neuron (SMN) Gene
J. Biol. Chem., April 9, 2004; 279(15): 14803 - 14811.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Miyaso, M. Okumura, S. Kondo, S. Higashide, H. Miyajima, and K. Imaizumi
An Intronic Splicing Enhancer Element in Survival Motor Neuron (SMN) Pre-mRNA
J. Biol. Chem., April 25, 2003; 278(18): 15825 - 15831.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
V Cusin, O Clermont, B Gerard, D Chantereau, and J Elion
Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counselling
J. Med. Genet., April 1, 2003; 40(4): e39 - 39.
[Full Text] [PDF]

Home page
 NeurologyHome page
S. Rudnik-Schoneborn, H.H. Goebel, W. Schlote, S. Molaian, H. Omran, U. Ketelsen, R. Korinthenberg, D. Wenzel, H. Lauffer, M. Kreiss-Nachtsheim, et al.
Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy
Neurology, March 25, 2003; 60(6): 983 - 987.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Miyajima, H. Miyaso, M. Okumura, J. Kurisu, and K. Imaizumi
Identification of a Cis-acting Element for the Regulation of SMN Exon 7 Splicing
J. Biol. Chem., June 21, 2002; 277(26): 23271 - 23277.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. J. DiDonato, C. L. Lorson, Y. De Repentigny, L. Simard, C. Chartrand, E. J. Androphy, and R. Kothary
Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing
Hum. Mol. Genet., November 1, 2001; 10(23): 2727 - 2736.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Andreassi, J. Jarecki, J. Zhou, D. D. Coovert, U. R. Monani, X. Chen, M. Whitney, B. Pollok, M. Zhang, E. Androphy, et al.
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients
Hum. Mol. Genet., November 1, 2001; 10(24): 2841 - 2849.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
V. Wong and V. Chan
Molecular Genetic Study of a Childhood Form of Spinal Muscular Atrophy
J Child Neurol, April 1, 2001; 16(4): 291 - 294.
[Abstract] [PDF]

Home page
 Hum Mol GenetHome page
U. R. Monani, D. D. Coovert, and A. H.M. Burghes
Animal models of spinal muscular atrophy
Hum. Mol. Genet., October 1, 2000; 9(16): 2451 - 2457.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Hofmann, C. L. Lorson, S. Stamm, E. J. Androphy, and B. Wirth
Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)
PNAS, August 6, 2000; (2000) 160181697.
[Abstract] [Full Text]

Home page
 Hum Mol GenetHome page
N. Owen, C. L. Doe, J. Mellor, and K. E. Davies
Characterization of the Schizosaccharomyces pombe orthologue of the human survival motor neuron (SMN) protein
Hum. Mol. Genet., March 22, 2000; 9(5): 675 - 684.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
B. Charroux, L. Pellizzoni, R. A. Perkinson, A. Shevchenko, M. Mann, and G. Dreyfuss
Gemin3: A Novel Dead Box Protein That Interacts with Smn, the Spinal Muscular Atrophy Gene Product, and Is a Component of Gems
J. Cell Biol., December 13, 1999; 147(6): 1181 - 1194.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. L. Lorson, E. Hahnen, E. J. Androphy, and B. Wirth
A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy
PNAS, May 25, 1999; 96(11): 6307 - 6311.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
I. Biros and S. Forrest
Spinal muscular atrophy: untangling the knot?
J. Med. Genet., January 1, 1999; 36(1): 1 - 8.
[Abstract] [Full Text]

Home page
 J Child NeurolHome page
H. Omran, U.-P. Ketelsen, F. Heinen, M. Sauer, S. Rudnik-Schonebom, B. Wirth, K. Zerres, W. Kratzer, and R. Korinthenberg
Axonal Neuropathy and Predominance of Type II Myofibers in Infantile Spinal Muscular Atrophy
J Child Neurol, July 1, 1998; 13(7): 327 - 331.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
L. P. Rowland
Molecular Basis of Genetic Heterogeneity: Role of the Clinical Neurologist
J Child Neurol, March 1, 1998; 13(3): 122 - 132.
[Abstract] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Schrank, R. Gotz, J. M. Gunnersen, J. M. Ure, K. V. Toyka, A. G. Smith, and M. Sendtner
Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos
PNAS, September 2, 1997; 94(18): 9920 - 9925.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
C. J. DiDonato, X.-N. Chen, D. Noya, J. R. Korenberg, J. H. Nadeau, and L. R. Simard
Cloning, Characterization, and Copy Number of the Murine Survival Motor Neuron Gene: Homolog of the Spinal Muscular Atrophy-Determining Gene
Genome Res., April 1, 1997; 7(4): 339 - 352.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. J. Friesen and G. Dreyfuss
Specific Sequences of the Sm and Sm-like (Lsm) Proteins Mediate Their Interaction with the Spinal Muscular Atrophy Disease Gene Product (SMN)
J. Biol. Chem., August 18, 2000; 275(34): 26370 - 26375.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Wang and G. Dreyfuss
A Cell System with Targeted Disruption of the SMN Gene. FUNCTIONAL CONSERVATION OF THE SMN PROTEIN AND DEPENDENCE OF Gemin2 ON SMN
J. Biol. Chem., March 23, 2001; 276(13): 9599 - 9605.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Wang and G. Dreyfuss
Characterization of Functional Domains of the SMN Protein in Vivo
J. Biol. Chem., November 21, 2001; 276(48): 45387 - 45393.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. J. Young, P. M. Day, J. Zhou, E. J. Androphy, G. E. Morris, and C. L. Lorson
A Direct Interaction between the Survival Motor Neuron Protein and p53 and Its Relationship to Spinal Muscular Atrophy
J. Biol. Chem., January 18, 2002; 277(4): 2852 - 2859.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Hofmann, C. L. Lorson, S. Stamm, E. J. Androphy, and B. Wirth
Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)
PNAS, August 15, 2000; 97(17): 9618 - 9623.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.